Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Softing AG Board/Management Information 2002

May 28, 2002

405_rns_2002-05-28_f7563f9a-ec61-463b-b6a1-6c79aed3cd01.html

Board/Management Information

Open in viewer

Opens in your device viewer

News Details

Ad-hoc | 28 May 2002 08:32

Softing AG english

Dr. Wolfgang Trier has been Appointed Chairman of the Executive Board of Softing Ad-hoc-announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. ——————————————————————————– Dr. Wolfgang Trier has been Appointed Chairman of the Executive Board of Softing Dr. Wolfgang Trier, member of the Executive Board of Softing AG since April 1, 2002, has been appointed Chairman of the Executive Board with effect from June 1, 2002. In addition to the tasks in connection with this position, Dr. Trier will also assume the operative responsibility for the marketing subsidiary Softing North America, Inc., the legal issues, and the departments Public Relations and Investor Relations. The main task of Dr. Trier for the year 2002 will be the consistent repositioning of Softing AG. This includes a comprehensive program for improving the company’s position in terms of sales and revenue. In concrete terms, Dr. Trier will further promote the sales activities and, in connection with this, the focus on product sales. For fast and substantial improvement of the company’s efficiency, the Executive Board of Softing AG will take measures to improve internal costs at short and medium notice. The objective of the repositioning program is to achieve a sustained positive result and cash flow as of 2003. end of ad-hoc-announcement (c)DGAP 28.05.2002 ——————————————————————————– WKN: 517800; ISIN: DE0005178008; Index: Listed: Neuer Markt in Frankfurt; Freiverkehr in Berlin, Bremen, Düsseldorf, Hamburg, Hannover, München, Stuttgart 280832 Mai 02